Skip to main content

J. William Tanner, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when CervoMed Inc. publishes a filing, an earnings call transcript or a press release.

Get CRVO alerts

About J. William Tanner, Ph.D.

J. William Tanner, Ph.D. is recorded as CFO at CervoMed Inc. (CRVO) since November 15, 2023. CervoMed Inc. reported in an 8-K filed May 20, 2024 that J. William Tanner, Ph.D. was terminated as Chief Financial Officer, effective May 31, 2024. CervoMed Inc. reported in an 8-K filed November 17, 2023 that J. William Tanner, Ph.D. was appointed Chief Financial Officer, effective November 15, 2023. CervoMed Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CervoMed Inc. includes John Alam, M.D. (CEO and Board Member), Robert J. Cobuzzi (CEO), Robert J. Cobuzzi Jr., Ph.D. (CEO) and 7 others.

“Dr. Tanner’s employment with the Company will terminate effective May 31, 2024, and, effective June 1, 2024, Dr. Tanner will begin service as a consultant to the Company.”
CervoMed Inc. Form 8-K, filed May 20, 2024 · Read the filing
“Effective November 15, 2023, CervoMed Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with J. William Tanner, Ph.D., the Company’s Chief Financial Officer. Pursuant and subject to the terms and conditions of the Employment Agreement, Dr. Tanner will serve as the Company’s Chief Financial Officer and receive an initial monthly base salary of $18,000, subject to increase at the discretion of the Company’s board of directors.”
CervoMed Inc. Form 8-K, filed November 17, 2023 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

CFO

2023-11-15–present

Leadership on record at CervoMed Inc.

Recent activity